Saturday 17 October 2026
Export AVR’s income statement to Excel — free account
Anteris Technologies Global Corp.
AVR Healthcare Medical Instruments & Supplies
Anteris Technologies Global Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, down 29.2% from fiscal 2024. In the quarter to June 2026, revenue grew 63.3%, EPS grew 48.3%, free cash flow fell 6.84% and total debt rose 8.15%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
6.05
0.31
−4.87%
Follow AVR
| Dec '25 | Dec '24 | Dec '23 | |
|---|---|---|---|
Piotroski F-Score |
2 | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 |
Altman Z-Score |
(31.49) | (3.34) | — |
P/S ratio |
96.28 | 41.81 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(81.60) | (9.32) | (26.95) |
P/FCF ratio |
0.00 | 0.00 | 0.00 |
Beneish M-Score |
(6.30) | (4.28) | — |
P/Operating CF |
(9.94) | (6.20) | (8.15) |
P/B ratio |
0.00 | 1.80 | 6.08 |
Price to Tangible BV |
0.00 | 1.81 | 6.08 |
EV/Sales |
89.73 | 15.75 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
(2.21) | (0.69) | (1.22) |
EV/FCF |
(2.15) | (0.67) | (1.19) |
Quick Ratio |
0.59 | 4.27 | 2.27 |
Current Ratio |
0.73 | 4.51 | 2.56 |
Net Debt/EBITDA |
0.14 | 0.92 | 0.43 |
Debt/Assets |
0.17% | 0.00% | 3.07% |
Debt/Equity |
(0.15) | 0.00 | 0.05 |
Asset Turnover |
0.04 | 0.05 | 0.00 |
Operating CF/Net income |
0.83 | 0.80 | 0.75 |
Capex/Depreciation |
(1.18) | (1.51) | (2.05) |
Interest Coverage |
(1,286.22) | (1,667.49) | (709.04) |
| (301.60%) | (187.03%) | 0.00% | |
| (181.58%) | (137.18%) | 0.00% | |
ROIC |
0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
21,592.66% | (121.36%) | (244.80%) |
Average Days of Receivables |
6.11 | 28.09 | 54.45 |
Research and Development Expense of Revenue |
3,613.17% | 1,903.48% | 1,129.43% |
Selling, General and Administrative Expense of Revenue |
1,365.29% | 1,042.80% | 634.77% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.01 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% |
Graham Net Nets |
(0.04) | 0.50 | 0.11 |
Graham Number |
0.63 | 0.00 | 0.00 |
Earnings Yield |
(51.30%) | (67.22%) | (67.22%) |
Free Cash Flow Yield |
(43.30%) | (56.20%) | (69.21%) |
Revenue per Share |
0.05 | 0.13 | 0.18 |
Operating CF per Share |
(2.11) | (3.02) | (2.22) |
Capex per Share |
(0.05) | (0.11) | (0.15) |
Free Cash Flow per Share |
(2.16) | (3.14) | (2.37) |
Cash per Share |
0.34 | 3.48 | 1.35 |
Shareholders Equity per Share |
(0.01) | 3.10 | 1.21 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
(0.01) | 3.10 | 1.21 |
Free Cash Flow |
(79.76) | (63.52) | (37.00) |
Working Capital |
(5.70) | 58.09 | 14.77 |
Capital Expenditures |
(1.95) | (2.28) | (2.37) |
Net Current Asset Value |
(7.57) | 56.63 | 12.59 |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
1.02 | 0.84 | 0.87 |
Price to Operating Income |
0.00 | 0.00 | 0.00 |
| Other line items | |||
Depreciation/Fixed assets |
0.32 | 0.32 | 0.29 |
Cash ROIC |
(645.23%) | (47.71%) | (90.41%) |
Accounts Receivable Turnover |
15.94 | 8.78 | 0.00 |
Accounts Payable Turnover |
0.07 | 0.32 | 0.00 |
Inventory Turnover |
1.71 | 3.01 | 0.00 |
Average Days of Payables |
7,116.54 | 1,495.81 | 616.65 |
Days of Inventory on Hand |
97.50 | 130.30 | 86.83 |
Average Receivables |
0.12 | 0.31 | — |
Average Payables |
8.49 | 4.51 | — |
Average Inventory |
0.33 | 0.48 | — |
Average Assets |
51.85 | 55.61 | — |
Average Common Equity |
31.21 | 40.79 | — |
Columns are period end dates